Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-Small Cell Lung Carcinoma
|
712 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.070 | 1.000 | 7 | 2008 | 2013 | ||||
Breast Carcinoma
|
2793 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.100 | 0.913 | 23 | 2009 | 2018 | ||||
Malignant neoplasm of breast
|
3417 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.100 | 0.870 | 23 | 2009 | 2018 | ||||
Carcinoma of lung
|
1204 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.100 | 0.944 | 18 | 2009 | 2018 | ||||
Malignant neoplasm of lung
|
1142 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.100 | 0.944 | 18 | 2009 | 2018 | ||||
Primary malignant neoplasm of lung
|
981 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.100 | 0.944 | 18 | 2009 | 2018 | ||||
Coronary heart disease
|
1178 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.030 | 1.000 | 3 | 2009 | 2019 | ||||
Congenital heart disease
|
80 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Liver carcinoma
|
942 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.100 | 0.684 | 19 | 2010 | 2019 | ||||
Malignant neoplasm of stomach
|
615 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.100 | 0.727 | 11 | 2010 | 2017 | ||||
Stomach Carcinoma
|
652 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.100 | 0.700 | 10 | 2010 | 2017 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.060 | 1.000 | 6 | 2010 | 2019 | ||||
Neoplasms
|
1644 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.050 | 1.000 | 5 | 2010 | 2018 | ||||
Squamous cell carcinoma of the head and neck
|
348 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.040 | 1.000 | 4 | 2010 | 2016 | ||||
Glioma
|
353 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.020 | 1.000 | 2 | 2010 | 2017 | ||||
Anthracosis
|
37 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Cardiomyopathy, Familial Idiopathic
|
243 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Gallbladder Carcinoma
|
75 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Malignant neoplasm of gallbladder
|
81 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Stage IIA Gallbladder Cancer AJCC v8
|
56 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Stage IIB Gallbladder Cancer AJCC v8
|
56 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Stage III Gallbladder Cancer AJCC v8
|
56 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Stage IV Gallbladder Cancer AJCC v8
|
56 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Malignant Neoplasms
|
1641 | 0.512 | 0.760 | 12 | 53991815 | mature miRNA variant | C/T | snv | 0.39 | 0.34 | 0.100 | 0.957 | 23 | 2011 | 2019 |